Clinical Trial Update: Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating tolerability of peginterferon plus ribavirin in chronic hepatitis C with and without antiretroviral therapy for HIV co-infected patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (Pegasys) (peginterferon alfa-2a)
• Ribavirin (Copegus) (ribavirin)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Chronic Hepatitis C, HIV Infections | Phase 3 | Status: TERMINATED